Gainesville, FL


Axogen is developing a proprietary nerve graft to repair and regenerate damaged peripheral nerves.

CryoVascular Systems

Los Gatos, CA

(Acquired by Boston Scientific)

CryoVascular Systems has developed a cryogenic balloon catheter for treating disease in coronary and peripheral arteries.

Fox Hollow Technologies

Redwood City, CA


Fox Hollow Technologies has developed a unique device to remove plaque or diseased tissue from coronary and peripheral arteries. Fox Hollow Technologies merged with ev3, Inc. (NASDAQ: EVVV) in October 2007.

Hansen Medical

Mountain View, CA


Hansen Medical develops automated solutions to enhance catheter placement for interventional cardiovascular procedures.

InSound Medical

Newark, CA

(Acquired by Sonova Group)

InSound Medical is a company developing leading edge technologies for the hearing impaired.

Loma Vista Medical

Burlingame, CA

(Acquired by C.R. Bard)

Loma Vista Medical is developing cutting-edge products in medical inflatables.


Redwood City, CA

(Acquired by Cordis/Johnson & Johnson)

LuMend has developed devices to treat chronic total occlusions (CTOs) in the peripheral and coronary arteries.


Aliso Viejo, CA

(Acquired by Terumo)

MicroVention sells a unique catheter-based implant for the treatment of cerebral aneurysms as an alternative to an invasive craniotomy.

OncoMed Pharmaceuticals

Redwood City, CA


OncoMed, Inc. is developing antibody therapeutics targeting cancer stem cells, a cancer cell population responsible for cancer growth, recurrence, and metastases.

Precision Light, Inc.

Los Gatos, CA

(Acquired by Allergan Inc.)

Precision Light, Inc. is developing a 3-D imaging system for use by plastic surgeons to enhance breast augmentation surgery.


South San Francisco, CA


Renovis develops drugs for the treatment of neurological and psychological diseases.


Aliso Viejo, CA


SenoRx develops and sells products used in the diagnosis and therapy of breast disease.


Santa Rosa, CA

(Acquired by Boston Scientific)

TriVascular develops next-generation endovascular grafts for the treatment of aortic aneurysms.